Atara Biotherapeutics, Inc. (ATRA)
4.18
-0.06
(-1.42%)
USD |
NASDAQ |
Feb 20, 16:00
4.17
-0.01
(-0.24%)
After-Hours: 20:00
Atara Biotherapeutics Market Cap : 30.14M for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 44.59B |
| Pfizer Inc. | 151.52B |
| Vertex Pharmaceuticals, Inc. | 121.15B |
| AbbVie, Inc. | 397.33B |
| ACADIA Pharmaceuticals, Inc. | 4.059B |
Market Cap Related Metrics
| PE Ratio | 1.907 |
| PS Ratio | 0.3261 |
| Price | 4.18 |
| Earnings Yield | 52.44% |
| Operating PE Ratio | 1.318 |
| Normalized PE Ratio | 1.435 |